240 results on '"Choi, Y-L."'
Search Results
2. Encapsulated zerovalent iron/nickel-fly ash zeolite foam for treating industrial wastewater contaminated by heavy metals
3. HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients
4. EP06.03-05 EGFR Exon 20 Insertion Mutations in NSCLC: The Need for Accurate Naming Conventions and Implications for Personalized Therapy
5. EP06.03-02 Elucidating Tumor Heterogeneity from Spatially Resolved Transcriptomics in ALK-Rearranged Non-small Cell Lung Cancer
6. OA20.04 Clinical Significance of IASLC Proposed Pathologic Criteria for Invasion in Resected Non-mucinous Lung Adenocarcinoma
7. P1.11-05 Application of the CRISPR/Cas9-based Gene Editing Technology for the Treatment of NUT Carcinoma
8. P1.22-02 Whole Genome Sequencing Analysis of ALK-rearranged Non-small Cell Lung Cancer
9. Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial
10. Correction: ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells
11. Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing
12. OD1-1 Preliminary results from the KOrean precision medicine networking group study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors (KOSMOS): KCSG AL-20-05
13. 225P MET-enriched circulating tumor cells and cell-free DNA concentration as significant independent predictors for progression in HR-positive HER2-negative metastatic breast cancer
14. 1216P Adjuvant pembrolizumab therapy for completely resected stage I NSCLC with micropapillary or solid histological subtype
15. 5P Exploratory biomarker analysis from neoadjuvant atezolizumab, pertuzumab, trastuzumab plus docetaxel (NEO-PATH) in HER2+ early breast cancer
16. Diagnostic performance of conventional MRI parameters and apparent diffusion coefficient values in differentiating between benign and malignant soft-tissue tumours
17. 1805P Assistance with an artificial intelligence-powered PD-L1 analyzer reduces interobserver variation in pathologic reading of tumor proportion score in non-small cell lung cancer
18. Erratum: ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells
19. 2330P Pre-test prediction of multiple druggable mutations based on H&E image artificial intelligence (AI) analysis may enable more efficient clinical workflow for treatment decisions in non-small cell lung cancer (NSCLC)
20. 708P Final clinical outcomes of nationwide precision oncology pilot study; KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS) KCSG AL-20-05
21. Array-based genomic resequencing of human leukemia
22. High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays
23. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer
24. MicroRNA expression profiles of human leukemias
25. Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer
26. 135P The real-world use of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor mutated (EGFRm) advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC) patients
27. 143P Physician perceptions of barriers to epidermal growth factor receptor mutation (EGFRm) testing in advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC)
28. 144P Delays in epidermal growth factor receptor mutation (EGFRm) testing in advanced (stage IIIb/ IIIc/ IV) non-small cell lung cancer (NSCLC) patients and their impact on the use of first line tyrosine kinase inhibitor (TKIs) in a real-world setting
29. Analysis of chromosome copy number in leukemic cells by different microarray platforms
30. A genomic analysis of adult T-cell leukemia
31. Cloning, purification, and characterization of chitosanase from Bacillus sp. DAU101
32. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability
33. DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3−CD56+ fractions
34. DNA microarray analysis of hematopoietic stem cell-like fractions from individuals with the M2 subtype of acute myeloid leukemia
35. The role of arthroscopic synovectomy in patients with undifferentiated chronic monoarthritis of the wrist
36. Supplement to: EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.
37. Extranodal NK/T-cell lymphoma with cutaneous involvement: ‘nasal’ vs. ‘nasal-type’ subgroups— a retrospective study of 18 patients
38. Radiofrequency thyroarytenoid myothermy for treatment of adductor spasmodic dysphonia: how we do it
39. Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients
40. CD10 is expressed in dermal sheath cells of the hair follicles in human scalp
41. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables
42. Aggressive NK-cell leukaemia associated with reactive haemophagocytic syndrome
43. Evaluation of Neurocognitive Function on Complex Sensory Stimulation of Acoustic Wave Vibration Chair
44. Abstract PD5-08: Neoadjuvant chemotherapy alters the genomic landscape and immune microenvironment of breast cancers
45. Supplementary Material for: Detection of Human Papillomavirus DNA by DNA Chip in Breast Carcinomas of Korean Women
46. Delayed bleeding after gamma knife surgery for meningioma
47. Tumor-infiltrating CD3+ lymphocytes and ICOS+ T-cells predict a favorable survival in resected esophageal squamous cell carcinoma
48. Abstract P2-07-01: Integrative analyses of immunophenotypes and multi-omics profiles in breast cancers
49. ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cellsThis article has been corrected since Advance Online Publication and an erratum is also printed in this issue
50. Abstract P1-05-15: Multi-omics and immuno-oncology profiling reveal distinct molecular signatures of young Asian breast cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.